Motley Fool Asset Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $7.03M | Buy |
15,794
+1,875
| +13% | +$835K | 0.32% | 62 |
|
2025
Q1 | $6.75M | Buy |
13,919
+435
| +3% | +$211K | 0.38% | 58 |
|
2024
Q4 | $5.43M | Buy |
13,484
+1,840
| +16% | +$741K | 0.28% | 74 |
|
2024
Q3 | $5.47M | Buy |
11,644
+613
| +6% | +$288K | 0.32% | 73 |
|
2024
Q2 | $5.2M | Buy |
11,031
+2,510
| +29% | +$1.18M | 0.34% | 69 |
|
2024
Q1 | $3.56M | Buy |
8,521
+928
| +12% | +$388K | 0.23% | 86 |
|
2023
Q4 | $3.09M | Buy |
7,593
+361
| +5% | +$147K | 0.23% | 86 |
|
2023
Q3 | $2.51M | Buy |
7,232
+682
| +10% | +$237K | 0.2% | 89 |
|
2023
Q2 | $2.31M | Buy |
+6,550
| New | +$2.31M | 0.21% | 86 |
|
2023
Q1 | – | Sell |
-6,303
| Closed | -$1.82M | – | 203 |
|
2022
Q4 | $1.82M | Sell |
6,303
-190
| -3% | -$54.9K | 0.21% | 86 |
|
2022
Q3 | $1.88M | Sell |
6,493
-47
| -0.7% | -$13.6K | 0.18% | 90 |
|
2022
Q2 | $1.89M | Sell |
6,540
-245
| -4% | -$70.8K | 0.18% | 95 |
|
2022
Q1 | $1.77M | Buy |
6,785
+195
| +3% | +$50.9K | 0.13% | 110 |
|
2021
Q4 | $1.45M | Buy |
6,590
+53
| +0.8% | +$11.6K | 0.09% | 123 |
|
2021
Q3 | $1.19M | Buy |
6,537
+365
| +6% | +$66.2K | 0.08% | 135 |
|
2021
Q2 | $1.24M | Buy |
6,172
+168
| +3% | +$33.9K | 0.08% | 130 |
|
2021
Q1 | $1.29M | Sell |
6,004
-89
| -1% | -$19.1K | 0.09% | 120 |
|
2020
Q4 | $1.44M | Buy |
6,093
+511
| +9% | +$121K | 0.11% | 109 |
|
2020
Q3 | $1.53M | Buy |
5,582
+663
| +13% | +$181K | 0.14% | 97 |
|
2020
Q2 | $1.43M | Buy |
4,919
+623
| +15% | +$181K | 0.14% | 90 |
|
2020
Q1 | $1.02M | Sell |
4,296
-341
| -7% | -$81.1K | 0.13% | 102 |
|
2019
Q4 | $1.02M | Hold |
4,637
| – | – | 0.11% | 105 |
|
2019
Q3 | $786K | Buy |
4,637
+362
| +8% | +$61.4K | 0.09% | 115 |
|
2019
Q2 | $784K | Buy |
4,275
+322
| +8% | +$59.1K | 0.09% | 118 |
|
2019
Q1 | $727K | Buy |
3,953
+854
| +28% | +$157K | 0.08% | 116 |
|
2018
Q4 | $514K | Buy |
3,099
+294
| +10% | +$48.8K | 0.07% | 122 |
|
2018
Q3 | $541K | Buy |
2,805
+130
| +5% | +$25.1K | 0.07% | 110 |
|
2018
Q2 | $455K | Buy |
2,675
+420
| +19% | +$71.4K | 0.06% | 113 |
|
2018
Q1 | $368K | Buy |
+2,255
| New | +$368K | 0.05% | 117 |
|